How openly accessible is pharma-sponsored research?
openacrs's bookmarks 2021-04-17
Summary:
Why was this needed?
- Previous investigations into the open access rates of industry-sponsored research either come from individual company assessments of proprietary data, using different methods to detect the open access status of publications, or from manual analyses of pre-existing cross-company data sets (such as the Good Pharma Scorecard).
- Direct comparison of open access publishing rates between pharmaceutical companies has therefore not been possible.
What did we do?
- Here, we present an automated and reproducible method to assess the 2019 open access rates of company-sponsored publications across the pharmaceutical industry, using informatic technology and publicly available data.